Menarini Group and Radius Health Announce Global License Agreement for the Development and Commercia

- Menarini licenses global development and commercialization rights of elacestrant, an oral SERD currently in late stage Phase 3 development - Elacestrant further ... Lees verder

Bron:

ANP Pers support